Csaba Bödör
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 36
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Hematology top 5%
- Acute Myeloid Leukemia Research 18
- Chronic Myeloid Leukemia Treatments 10
-
- Lymphoma Diagnosis and Treatment 40
- Immunology top 10%
- Oncology top 10%
- Viral-associated cancers and disorders 9
-
- Cancer Genomics and Diagnostics 17
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- András MatolcsyJudit CsomorJohn G. GribbenÁgota SzepesiKatalin DezsőSameena IqbalPéter NagyJude Fitzgibbon
- Partner nations
- HungaryUnited KingdomUnited States
In The Last Decade
Csaba Bödör
102 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Genetics 377
- Hematology 246
- Pathology and Forensic Medicine 377
- Immunology 363
- Oncology 335
Countries citing papers authored by Csaba Bödör
This map shows the geographic impact of Csaba Bödör's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Csaba Bödör with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Csaba Bödör more than expected).
Fields of papers citing papers by Csaba Bödör
This network shows the impact of papers produced by Csaba Bödör. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Csaba Bödör. The network helps show where Csaba Bödör may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Csaba Bödör, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 13 | |
| 13 | 2023 | 0 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 18 | |
| 16 | 2020 | 64 | |
| 17 | 2018 | 8 | |
| 18 | 2018 | 5 | |
| 19 | 2017 | 8 | |
| 20 | 2012 | 64 |
About Csaba Bödör
Csaba Bödör is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Cancer Research and Immunology, having authored 116 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (36 papers), Acute Myeloid Leukemia Research (18 papers), Cancer Genomics and Diagnostics (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Chronic Myeloid Leukemia Treatments (10 papers), Viral-associated cancers and disorders (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Genetics (377 citations), Hematology (246 citations), Pathology and Forensic Medicine (377 citations), Immunology (363 citations) and Oncology (335 citations). Csaba Bödör has collaborated with scholars based in Hungary, United Kingdom and United States. Frequent co-authors include András Matolcsy, Judit Csomor, John G. Gribben, Ágota Szepesi, Katalin Dezső, Sameena Iqbal, Péter Nagy, Jude Fitzgibbon, Sándor Paku and Balázs Csernus. Their work appears in journals such as Pathology & Oncology Research, Blood, Hematological Oncology, PLoS ONE and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.